Contents

Current Pharmaceutical Design, Volume 10 - Number 11

Foreword

, 10(11): i

Ken Bradstock


DOI: 10.2174/1381612043452622




Small Molecule FLT3 Tyrosine Kinase Inhibitors

, 10(11): 1183 - 1193

Mark Levis and Donald Small


DOI: 10.2174/1381612043452604




Anti-Cytokine Therapy for the Treatment of Graft-Versus-Host Disease

, 10(11): 1195 - 1205

David A. Jacobsohn and Georgia B. Vogelsang


DOI: 10.2174/1381612043452569




Ex-Vivo Uses and Applications of Cytokines for Adoptive Immunotherapy in Cancer

, 10(11): 1207 - 1220

Aaron E. Foster, Kurt Forrester, Yi-Chiao Li and David J. Gottlie


DOI: 10.2174/1381612043452631




Antiangiogenic Therapy in Hematologic Malignancies

, 10(11): 1221 - 1234

Moehler T. M., Hillengass J., Goldschmidt H. and Ho A. D.


DOI: 10.2174/1381612043452587




The Design and Development of Pegfilgrastim (PEG-rmetHuG-CSF, Neulasta®)

, 10(11): 1235 - 1244

G. Molineux


DOI: 10.2174/1381612043452613




Chemokines and their Receptors as Therapeutic Targets: The Role of the SDF-1 / CXCR4 Axis

, 10(11): 1245 - 1259

Julius Juarez, Linda Bendall and Ken Bradstock


DOI: 10.2174/1381612043452640




Molecular Mechanisms Explaining the Preventive Effects of Catechins On the Development of Proliferative Diseases

, 10(11): 1261 - 1271

I. Gouni-Berthold and A. Sachinidis


DOI: 10.2174/1381612043452578




A Systematic Approach to Simulating Metabolism in Computational Toxicology. I. The TIMES Heuristic Modelling Framework

, 10(11): 1273 - 1293

Ovanes G. Mekenyan, Sabcho D. Dimitrov, Todor S. Pavlov and Gilman D. Veith


DOI: 10.2174/1381612043452596




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science